-
公开(公告)号:US06870028B1
公开(公告)日:2005-03-22
申请号:US09593417
申请日:2000-06-14
申请人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michael Roberge , Theresa Allen
发明人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michael Roberge , Theresa Allen
CPC分类号: C07K5/0205 , A61K38/00 , C07K5/0827
摘要: This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
摘要翻译: 本发明涉及具有抗有丝分裂活性并可用于治疗癌症的半球蛋白或衍生物的衍生物。 这些衍生物由通式I表示,其中Y,n,R 1,R 2,R 3,R 6,R 7,R 70,R 71,R 72,R 74和R 75如说明书中所定义。
-
公开(公告)号:US07410951B2
公开(公告)日:2008-08-12
申请号:US11034922
申请日:2005-01-14
申请人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Theresa Allen
发明人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Theresa Allen
IPC分类号: C07K5/06
CPC分类号: C07K5/0205 , A61K38/00 , C07K5/0827
摘要: Derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by formula I wherein Y, n, R1, R2, R3, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
摘要翻译: 具有抗有丝分裂活性并可用于治疗癌症的半精球蛋白或地高二聚G的衍生物。 这些衍生物由式I表示,其中Y,n,R 1,R 2,R 3,R 7, ,R 70,R 71,R 72,R 74和R 75, SUB>如说明书中所定义。
-
公开(公告)号:US07772397B2
公开(公告)日:2010-08-10
申请号:US12176716
申请日:2008-07-21
申请人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Theresa Allen
发明人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Theresa Allen
IPC分类号: C07D471/04
CPC分类号: C07K5/0205 , A61K38/00 , C07K5/0827
摘要: This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
摘要翻译: 本发明涉及具有抗有丝分裂活性并可用于治疗癌症的半球蛋白或衍生物的衍生物。 这些衍生物由通式I表示,其中Y,n,R 1,R 2,R 3,R 6,R 7,R 70,R 71,R 72,R 74和R 75如说明书中所定义。
-
公开(公告)号:US20090088573A1
公开(公告)日:2009-04-02
申请号:US12176716
申请日:2008-07-21
申请人: Raymond ANDERSEN , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Theresa Allen
发明人: Raymond ANDERSEN , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Theresa Allen
IPC分类号: C07D471/04
CPC分类号: C07K5/0205 , A61K38/00 , C07K5/0827
摘要: This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
摘要翻译: 本发明涉及具有抗有丝分裂活性并可用于治疗癌症的半球蛋白或衍生物的衍生物。 这些衍生物由通式I表示,其中Y,n,R 1,R 2,R 3,R 6,R 7,R 70,R 71,R 72,R 74和R 75如说明书中所定义。
-
公开(公告)号:US20050171137A1
公开(公告)日:2005-08-04
申请号:US11034922
申请日:2005-01-14
申请人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michael Roberge , Teresa Allen
发明人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michael Roberge , Teresa Allen
IPC分类号: A61K38/00 , A61P35/00 , C07K5/02 , C07K5/027 , C07K5/078 , C07K5/08 , C07K5/083 , A61K31/4745 , C07D471/02
CPC分类号: C07K5/0205 , A61K38/00 , C07K5/0827
摘要: This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
摘要翻译: 本发明涉及具有抗有丝分裂活性并可用于治疗癌症的半球蛋白或衍生物的衍生物。 这些衍生物由通式I表示,其中Y,n,R 1,R 2,R 3,R 6, R 7,R 70,R 71,R 72,R 74, / SUB>和R 75'如说明书中所定义。
-
公开(公告)号:US6153590A
公开(公告)日:2000-11-28
申请号:US930584
申请日:1998-02-02
申请人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Teresa Allen
发明人: Raymond Andersen , John Coleman , Dilip De Silva , Fangming Kong , Edward Piers , Debra Wallace , Michel Roberge , Teresa Allen
CPC分类号: C07K5/0205 , C07K5/0827 , A61K38/00
摘要: Compounds of general formula I ##STR1## wherein: R.sub.1 and R.sub.70 independently represent a hydrogen atom or an optionally substituted alkyl or acyl group; R.sub.2 represents a hydrogen atom or an optionally substituted alkyl or acyl group or is absent when R.sub.6 represents a group --CH.dbd. as hereinafter described; R.sub.73 represents a hydrogen atom or an optional substituent or is absent when R.sub.6 represents a methylene group or a group --CH.dbd. as hereinafter described; Y represents an optional substituent; n represents 0, 1, 2, 3, or 4; R.sub.3 represents a hydrogen atom, or an optionally substituted alkyl group; R.sub.74 represents a hydrogen atom, a hydroxy group or an optionally substituted alkyl or acyl group; R.sub.7 represents a hydrogen atom or an alkyl group; R.sub.75 represents an optionally substituted alkyl group; and i) R.sub.6 and R.sub.71 independently represent a hydrogen atom or an optionally substituted alkyl or acyl group; and R.sub.72 represents a hydrogen atom; or ii) R.sub.71 represents a hydrogen atom or an optionally susbtituted alkyl or acyl group and R.sub.72 represents a hydrogen atom or R.sub.71 and R.sub.72 are joined together such that a double bond is formed between the carbon atoms to which they are attached; and R.sub.6 represents an optionally substituted methylene group bonded to the indole moiety thereby forming a tricyclic moiety; or R.sub.6 represents an optionally substituted group --CH.dbd. bonded to the indole moiety thereby to form an aromatic tricyclic moiety; for use in therapy and as antimitotic reagents are described.
摘要翻译: PCT No.PCT / GB96 / 00942 Sec。 371日期1998年2月2日 102(e)1998年2月2日PCT 1996年4月22日PCT PCT。 出版物WO96 / 33211 日期:1996年10月24日通式I化合物其中:R 1和R 70独立地表示氢原子或任选取代的烷基或酰基; R2表示氢原子或任选取代的烷基或酰基,或当R6表示基团-CH =时不存在,如下所述; 当R 6表示亚甲基或-CH =如下所述时,R 73表示氢原子或任选的取代基或不存在; Y表示任选的取代基; n表示0,1,2,3或4; R3表示氢原子或任选取代的烷基; R 74表示氢原子,羟基或任选取代的烷基或酰基; R7表示氢原子或烷基; R75表示任选取代的烷基; 和i)R 6和R 71独立地表示氢原子或任选取代的烷基或酰基; R 72表示氢原子; 或ii)R 71表示氢原子或任选取代的烷基或酰基,R 72表示氢原子或R 71和R 72连接在一起,使得在它们所连接的碳原子之间形成双键; 并且R 6表示与吲哚部分键合的任选取代的亚甲基,从而形成三环部分; 或R6表示与吲哚部分键合的任选取代的基团-CH =,从而形成芳族三环部分; 用于治疗和用作抗有益剂的试剂。
-
公开(公告)号:US06914045B2
公开(公告)日:2005-07-05
申请号:US10131890
申请日:2002-04-25
申请人: Darren Robert Abbanat , Valerie Sue Bernan , Russell George Dushin , Michael Greenstein , Haiyin He , Stanley Albert Lang , Howard Newman , Subas Sakya , Phaik-Eng Sum , Alan Gordon Sutherland , Ting-Zhong Wang , Jason Arnold Lotvin , Mark Edward Ruppen , Arthur Emergy Bailey , Ping Cai , Bo Shen , Fangming Kong
发明人: Darren Robert Abbanat , Valerie Sue Bernan , Russell George Dushin , Michael Greenstein , Haiyin He , Stanley Albert Lang , Howard Newman , Subas Sakya , Phaik-Eng Sum , Alan Gordon Sutherland , Ting-Zhong Wang , Jason Arnold Lotvin , Mark Edward Ruppen , Arthur Emergy Bailey , Ping Cai , Bo Shen , Fangming Kong
IPC分类号: A61K38/00 , C07H15/203 , C07H19/04 , C07K9/00
CPC分类号: C07H15/203 , A61K38/00 , C07H19/04 , C07K9/008
摘要: The invention provides compounds of formula Wherein R1, R2, R3, R4, R5, R6a, R6b, R6c, R6d, R6e and R7 are defined in the specification. These compounds are useful as antibiotic agents.
-
公开(公告)号:US06649779B2
公开(公告)日:2003-11-18
申请号:US10162972
申请日:2002-06-05
申请人: Michael Z. Kagan , Fangming Kong , Leonard A. McDonald , Panolil Raveendranath , Syed M. Shah , Joseph Zeldis
发明人: Michael Z. Kagan , Fangming Kong , Leonard A. McDonald , Panolil Raveendranath , Syed M. Shah , Joseph Zeldis
IPC分类号: C07J100
CPC分类号: C07J1/00
摘要: This invention provides a pharmaceutically acceptable salt of 3&bgr;-hydroxy-5(10)-estrene-17-one 3-sulfate ester and a pharmaceutically acceptable salt of 3&agr;-hydroxy-5(10)-estrene-17-one 3-sulfate ester, which are useful as an estrogens.
-
公开(公告)号:US07018996B2
公开(公告)日:2006-03-28
申请号:US10618520
申请日:2003-07-11
IPC分类号: A61K38/12 , C07K7/64 , C07D401/00
摘要: This invention relates to antibiotics selected from the group AW998A, AW998B, AW998C and AW998D derived from the microorganism Streptomyces designated LL-AW998, which are useful as antibacterial agents.
摘要翻译: 本发明涉及选自可用作抗菌剂的来源于指定为LL-AW998的微生物Streptomyces的AW998A,AW998B,AW998C和AW998D的抗生素。
-
公开(公告)号:US06458778B1
公开(公告)日:2002-10-01
申请号:US09049485
申请日:1998-03-27
申请人: Fangming Kong , Leonard A. McDonald , Michael Z. Kagan , Syed M. Shah , Panolil Raveendranath , Mark A. Collins
发明人: Fangming Kong , Leonard A. McDonald , Michael Z. Kagan , Syed M. Shah , Panolil Raveendranath , Mark A. Collins
IPC分类号: A61K3156
CPC分类号: C07J1/00
摘要: This invention provides estra-5(10),7-dien-3&bgr;-ol-17-one or a pharmaceutically acceptable salt of its 3-sulfate ester, estra-5(10),7-dien-3&bgr;-ol-17-one 3-glucuronide or a pharmaceutically acceptable salt thereof, estra-5(10),7-dien-3&agr;-ol-17-one or a pharmaceutically acceptable salt of its 3-sulfate ester, estra-5(10),7-dien-3&bgr;-ol-17-one 3-glucuronide or a pharmaceutically acceptable salt thereof, estra-5(10),7-dien-3&bgr;-ol-17-one 3-alkali metal salt, and estra-5(10),7-dien-3&agr;-ol-17-one 3-alkali metal salt which are useful as estrogenic agents.
摘要翻译: 本发明提供雌甾-5(10),7-二烯-3β-醇-17-或其3-硫酸酯,雌-5(10),7-二烯-3β-醇-17-酮的药学上可接受的盐, 一种3-葡糖苷酸或其药学上可接受的盐,estra-5(10),7-二烯-3α-醇-17-或其3-硫酸酯的药学上可接受的盐,estra-5(10),7- 二烯-3β-醇-17-酮3-葡糖苷酸或其药学上可接受的盐,雌-5(10),7-二烯-3β-醇-17-酮3-碱金属盐和雌甾-5(10) ,7-二烯-3α-醇-17-酮3-碱金属盐,其可用作雌激素剂。
-
-
-
-
-
-
-
-
-